{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T16:14:03Z","timestamp":1719677643985},"reference-count":23,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1002\/jps.23112","type":"journal-article","created":{"date-parts":[[2012,3,14]],"date-time":"2012-03-14T14:32:48Z","timestamp":1331735568000},"page":"3169-3179","source":"Crossref","is-referenced-by-count":3,"title":["Osmotic Pellet System Comprising Osmotic Core and In-Process Amorphized Drug in Polymer\u2013Surfactant Layer for Controlled Delivery of Poorly Water-Soluble Drug"],"prefix":"10.1016","volume":"101","author":[{"given":"Nilesh","family":"Saindane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Vavia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.23112_bb0010","series-title":"Introduction of pharmacokinetics and pharmacodynamics: The quantitative basis of drug therapy","author":"Tozer","year":"2006"},{"key":"10.1002\/jps.23112_bb0015","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3109\/03639048909043666","article-title":"Bio-pharmaceutics and pharmacokinetics aspects in the design of controlled release per-oral drug delivery systems","volume":"15","author":"Ritschel","year":"1989","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1002\/jps.23112_bb0020","series-title":"Handbook of pharmaceutical controlled release technology","author":"Wise","year":"2000"},{"key":"10.1002\/jps.23112_bb0025","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1081\/DDC-100101287","article-title":"Osmotically controlled oral drug delivery","volume":"26","author":"Verma","year":"2000","journal-title":"Drug Dev Ind Pharm."},{"key":"10.1002\/jps.23112_bb0030","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/jps.2600641218","article-title":"Elementary osmotic pump","volume":"64","author":"Theeuwes","year":"1975","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23112_bb0035","series-title":"Osmotic system for the controlled and delivery of agent over time","author":"Theeuwes","year":"1978"},{"key":"10.1002\/jps.23112_bb0040","series-title":"Osmotic device with hydrogel driving member","author":"Cortese","year":"1982"},{"key":"10.1002\/jps.23112_bb0045","series-title":"Dosage form with improved delivery capability","author":"Stephens","year":"1989"},{"key":"10.1002\/jps.23112_bb0050","first-page":"841","article-title":"Preparation of controlled release coated tablets of naproxen sodium","volume":"37","author":"Lu","year":"2002","journal-title":"Chin Pharm J"},{"key":"10.1002\/jps.23112_bb0055","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejpb.2007.06.006","article-title":"Swellable elementary osmotic pump (SEOP): An effective device for delivery of poorly water-soluble drugs","volume":"68","author":"Shokri","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.23112_bb0060","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1002\/jps.20891","article-title":"Controlled porosity-osmotic pump pellets of a poorly water-soluble drug using sulfobutylether-\u03b2-cyclodextrin as a solubilizing and osmotic agent","volume":"96","author":"Sotthivirat","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23112_bb0065","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/03639040701657388","article-title":"Monolithic osmotic tablet containing solid dispersion of 10-hydroxycamptothecin","volume":"35","author":"Chen","year":"2009","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1002\/jps.23112_bb0070","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2174\/156720108785914998","article-title":"Pharmaceutical development of solid dispersion based osmotic drug delivery system for nifedipine","volume":"5","author":"Kanagale","year":"2008","journal-title":"Curr Drug Deliv"},{"key":"10.1002\/jps.23112_bb0075","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00003495-197918050-00001","article-title":"Glipizide: A review of its pharmacological properties and therapeutic use","volume":"18","author":"Brogden","year":"1979","journal-title":"Drugs"},{"key":"10.1002\/jps.23112_bb0080","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.2337\/diacare.17.12.1460","article-title":"Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM","volume":"17","author":"Berelowitz","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1002\/jps.23112_bb0085","series-title":"United States Pharmacopeia and National Formulary (USP 30-NF 25)","year":"2007"},{"key":"10.1002\/jps.23112_bb0090","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ejpb.2004.02.003","article-title":"Development and evaluation of osmotically controlled oral drug delivery system of glipizide","volume":"57","author":"Verma","year":"2004","journal-title":"Eur J Pharm and Biopharm"},{"key":"10.1002\/jps.23112_bb0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","article-title":"DDSolver: An add-in program for modeling and comparison of drug dissolution profiles","volume":"12","author":"Zhang","year":"2010","journal-title":"AAPS J"},{"key":"10.1002\/jps.23112_bb0100","series-title":"Handbook of pharmaceutical excipients, pharmaceutical press","author":"Rowe","year":"2003"},{"key":"10.1002\/jps.23112_bb0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0168-3659(00)00243-1","article-title":"Nifedipine controlled delivery by sandwiched osmotic tablet system","volume":"68","author":"Liu","year":"2000","journal-title":"J Control Release"},{"key":"10.1002\/jps.23112_bb0110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0168-3659(02)00482-0","article-title":"Controlled porosity osmotic pump-based controlled release system of pseudoephedrine","volume":"89","author":"Makhija","year":"2003","journal-title":"J Control Release"},{"key":"10.1002\/jps.23112_bb0115","doi-asserted-by":"crossref","first-page":"E-13","DOI":"10.1208\/pt0803053","article-title":"Formulation and optimization of porous osmotic pump-based controlled release system of oxybutynin","volume":"8","author":"Kanagale","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1002\/jps.23112_bb0120","series-title":"Novel drug delivery system","first-page":"85","author":"Chein","year":"1992"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915314301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915314301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T04:24:52Z","timestamp":1543119892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915314301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0022354915314301"],"URL":"https:\/\/doi.org\/10.1002\/jps.23112","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}